ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

Latest financial news

Celyad Presents Update on CYAD-01 Hematological Malignancies Clinical Program at 60th ASH Annual Meeting

Celyad Presents Update on CYAD-01 Hematological Malignancies Clinical Program at 60th ASH Annual Meeting

Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101

Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101

Celyad Announces Third Quarter 2018 Business Update

Celyad Announces Third Quarter 2018 Business Update

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Discover all financial news

Investor's kit

Annual Report 2017

Annual Report 2017

Celyad interim financial report H1 2018

Celyad interim financial report H1 2018

Celyad's investors presentation

Celyad's investors presentation

Financial Calendar

Want to see more?

Know more about our regulated information